1. Kabir, Ashraf Ul, Zeng, Carisa, Subramanian, Madhav, Artyomov, Maxim N, Choi, Kyunghee. 2024. ZBTB46 coordinates angiogenesis and immunity to control tumor outcome. In Nature immunology, 25, 1546-1554. doi:10.1038/s41590-024-01936-4. https://pubmed.ncbi.nlm.nih.gov/39134750/
2. Wang, Yu, Sun, He-Ying, Kumar, Sandeep, Jo, Hanjoong, Rezvan, Amir. 2018. ZBTB46 is a shear-sensitive transcription factor inhibiting endothelial cell proliferation via gene expression regulation of cell cycle proteins. In Laboratory investigation; a journal of technical methods and pathology, 99, 305-318. doi:10.1038/s41374-018-0060-5. https://pubmed.ncbi.nlm.nih.gov/29884909/
3. Carrera, Caty, Cárcel-Márquez, Jara, Cullell, Natalia, Montaner, Joan, Fernández-Cadenas, Israel. . Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma. In Brain : a journal of neurology, 144, 2416-2426. doi:10.1093/brain/awab090. https://pubmed.ncbi.nlm.nih.gov/33723576/
4. Chen, Wei-Yu, Zeng, Tao, Wen, Yu-Chng, Huang, Jiaoti, Liu, Yen-Nien. 2018. Androgen deprivation-induced ZBTB46-PTGS1 signaling promotes neuroendocrine differentiation of prostate cancer. In Cancer letters, 440-441, 35-46. doi:10.1016/j.canlet.2018.10.004. https://pubmed.ncbi.nlm.nih.gov/30312731/
5. Fararjeh, AbdulFattah Salah, Liu, Yen-Nien. 2019. ZBTB46, SPDEF, and ETV6: Novel Potential Biomarkers and Therapeutic Targets in Castration-Resistant Prostate Cancer. In International journal of molecular sciences, 20, . doi:10.3390/ijms20112802. https://pubmed.ncbi.nlm.nih.gov/31181727/